On January 24, 2022, Frost & Sullivan TradeGo LeadLeo Research Institute jointly authored the 'Investment Activity Report on the Issuance of 18A Biotech Companies in Hong Kong', which was officially released with Frost & Sullivan Frost & Sullivan (Shenzhen) Cloud Technology Co., Ltd.!
Since the Hong Kong Exchange implemented listing reforms in 2018, Hong Kong has become Asia's largest and the world's second-largest biotech financing center. The Hong Kong government has identified biotechnology as one of the key areas for innovation technology to support the future development of the industry. The capital market plays a crucial role in the development of biotechnology and in transmitting positive social impacts.
Hong Kong Stock Exchange 18A Biotech Companies' Issuance and Investment Activity ReportTherefore, this report was born out of necessity. It is based on the analysis of 48 listed companies in Hong Kong and 23 biotech enterprises that have not yet issued their prospectuses but have submitted their filings. The report provides an in-depth discussion from various dimensions such as industry overview and pre- and post-capital market issuance data, making it highly valuable for shareholders, investors, and intermediary service institutions in the biotech sector.
Hong Kong Stock Exchange 18A Biotech Companies' Issuance and Investment Activity Report
Table of Contents — Five Chapters in Total
-
Chapter 1: A Panorama of 18A Biotech Companies
Panorama - Total Panorama
Panoramic view - by site of onset
Panoramic view - by indication (pharmaceutical companies)
Panoramic view - by indication (medical device companies)
-
Chapter 2: Industry Analysis of 18A Biotechnology Companies
Pharmaceutical track
Medical device track
Frontier medical technology
-
Chapter 3: Issuance Data of 18A Biotech Company
Pre-issue data
Issued data
Post-issue data
intermediary agency
cornerstone investor
-
Chapter 4: Indexes of Biotech Companies Listed on the NASDAQ 18A and Outlook for Listing
Jielibio Technology Index Series Compilation Scheme
Operation Performance of Jile Biology Technology Index Series
Prospects for the Listing of BioTech Company 18A
-
Chapter 5: 18A Biotech Company Homepage
Display the corporate pages of 18A48 companies, including company introductions, R&D pipelines, issuance data, stock price trends, etc.
Hong Kong Stock Exchange 18A Biotech Companies' Issuance and Investment Activity ReportFrom planning, writing to finally printing into a book, the durationMore than three monthsTime, nearly300 pagesProofread and correctedDozens of timesThe number of contributors involved in compilation is nearly30 peopleParticipated in nearlyForty.
During the compilation process, it has received even moreHSBC Global BankingMr. Meng Yi, General Manager and Vice Chairman of China Region,Ping An CapitalMr. Zhou Yibang, a member of the Listing Committee of the Hong Kong Stock Exchange (Hong Kong) Limited,CMB InternationalMr Lau Shou-kin, Deputy Chief Executive Officer of (Holdings) Limited,Credit Suisse SecuritiesMr. Tu Lei, General Manager of (China) Co., Ltd.,EY Global Greater ChinaAccounting FirmJingtian Gongcheng Law Firm,Frost & SullivanComments and messages from colleagues in the medical team and other professionals on revisions/supplements.
The field of biotechnology is vast and knowledge is as endless as the sea, with new technologies and discoveries emerging daily. Humanity's demand for health is boundless, and the success of health research requires belief to be seen; biotechnology is related to the future of humanity.The motivation for writing, researching, and analyzing over more than 100 days and nights is to provide assistance to future issuers, investors in the pharmaceutical industry, and intermediary institutions. This aim is to enable them to better devote themselves to the tireless pursuit of life sciences, thereby seeking well-being for all mankind.
For the original report, please send an email to:livereport@sullivantelecloud.com
"18A Biotechnology Company's Issuance and Investment Activity Report"
Editor's Introduction
▶ Frost & Sullivan（Shenzhen）Cloud Technology Co., Ltd.
Founded jointly by the mainland subsidiaries of Frost & Sullivan Group and TradeGo. The cloud technology company provides one-stop full-cycle investor relations management and comprehensive investment and financing services for Hong Kong-listed companies planning to go public or those that are already listed, including precise promotional roadshows and public offerings. It is dedicated to the dissemination and realization of corporate value.
▶ Frost & Sullivan Limited
A global growth consulting firm, Frost & Sullivan specializes in the global capital markets and corporate consulting services. It provides a comprehensive range of investment and financing as well as various other professional consulting services for enterprises, including due diligence services, valuation services, assessment services, strategic consulting, management consulting, planning consulting, technical consulting, financial consulting, industry consulting, etc.
▶ TradeGo Financial Technology Co., Ltd.
TradeGo (08017.HK) provides an integrated terminal product for market and trading across over 140 Hong Kong brokers, serving more than 1.5 million Hong Kong stock trading users. TradeGo's proprietary APP has gathered over 60% of new investors in the IPO market and occupies an important position in assisting with public offerings on the Hong Kong capital market.
▶ LeadLeo International Ltd.
LeadLeo is a leading original corporate research content platform and new enterprise service provider in China. Leveraging its industry-leading corporate research content production capabilities, as well as experience in content operation and management, it has built a series of research products and solutions based on core technologies. With the core goal of helping enterprises accelerate the exploration, dissemination, and enhancement of capital value, LeadLeo comprehensively empowers over 50,000 professional users and is committed to becoming 'China's largest consulting cloud'.
